Biomedical Sciences
Global

Biomedical Sciences Experts

Stein Holst Annexstad

Broad of director
Bussiness
Ber Gen Bio
San Marino

Biography

Mr. Annexstad holds a BA in Commerce from the Norwegian School of Economics (1969). He has senior industry experience, both at executive and Board levels. He is former executive of Dyno Industrier AS (fine chemicals), and became the CEO of the pharmaceutical firm Nycomed AS (subsequently merged with Amersham Plc and thereafter merged with GE). He was head of AS Isco Group, an Executive Search and Corporate Advisory Group. Mr. Annexstad was in 1996 a co-founder of NorgesInvestor AS, an Oslo-based Private Equity firm, and was in 2008 the first Chairman of Investinor AS (the VC of the Norwegian State). At the same time he was Chairman of Algeta ASA, the pharmaceutical startup that successfully developed Xofigo (prostate cancer drug) and was aquired by Bayer Health Care in 2014. Other previous Chairman positions comprise commercial banking, business school, public R&D and various industrial enterprises.  

Research Interest

His research interests include fields health care  

Global Experts from San Marino

Global Experts in Subject